Microbot Medical Stock Today
| MBOT Stock | USD 0.87 0.02 2.25% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Microbot Medical is selling for under 0.87 as of the 20th of April 2024; that is -2.25 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.86. Microbot Medical has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Microbot Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of January 2024 and ending today, the 20th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of March 1992 | Category Healthcare | Classification Health Care |
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. The company has 14.4 M outstanding shares of which 173.28 K shares are now shorted by private and institutional investors with about 1.85 trading days to cover. More on Microbot Medical
Moving together with Microbot Stock
| 0.71 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Microbot Stock
| 0.78 | GCTK | GlucoTrack | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 15th of May 2024
Microbot Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Microbot Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Microbot Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Harel Gadot | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Drugs, Office Supplies, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Microbot Medical report their recommendations after researching Microbot Medical's financial statements, talking to executives and customers, or listening in on Microbot Medical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Microbot Medical. The Microbot consensus assessment is calculated by taking the average forecast from all of the analysts covering Microbot Medical. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Microbot Medical's profitability, liquidity, and operating efficiency, Microbot Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Microbot Medical is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microbot Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Microbot Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Microbot Medical's financial leverage. It provides some insight into what part of Microbot Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microbot Medical (MBOT) is traded on NASDAQ Exchange in USA. It is located in 288 Grove Street, Braintree, MA, United States, 02184 and employs 21 people. Microbot Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbot Medical's market, we take the total number of its shares issued and multiply it by Microbot Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Microbot Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 14.4 M outstanding shares of which 173.28 K shares are now shorted by private and institutional investors with about 1.85 trading days to cover.
Microbot Medical currently holds about 9.29 M in cash with (8.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Microbot Medical Probability Of Bankruptcy
Ownership AllocationMicrobot Medical holds a total of 14.4 Million outstanding shares. Roughly 86.0 % of Microbot Medical outstanding shares are held by general public with 1.680999999999999 pct. owned by insiders and only 12.27 % by institutional investors. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Microbot Ownership Details
Microbot Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Microbot Medical jumping above the current price in 90 days from now is close to 99%. The Microbot Medical probability density function shows the probability of Microbot Medical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.7692. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Microbot Medical will likely underperform. Additionally, microbot Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Microbot Medical to move above the current price in 90 days from now is close to 99 (This Microbot Medical probability density function shows the probability of Microbot Stock to fall within a particular range of prices over 90 days) .
Microbot Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Microbot Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Microbot Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Microbot Medical's value.| Instituion | Recorded On | Shares | |
| Hilltop Holdings Inc | 2023-12-31 | 20.3 K | |
| Two Sigma Securities, Llc | 2023-12-31 | 20.3 K | |
| Northern Trust Corp | 2023-12-31 | 13.4 K | |
| Wells Fargo & Co | 2023-12-31 | 12.8 K | |
| Taylor Frigon Capital Management Llc | 2023-12-31 | 12.5 K | |
| Xtx Topco Ltd | 2023-12-31 | 11.8 K | |
| Millennium Management Llc | 2023-12-31 | 11.5 K | |
| Stifel Financial Corp | 2023-12-31 | 10.3 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 10.2 K | |
| Vanguard Group Inc | 2023-12-31 | 459.5 K | |
| Armistice Capital, Llc | 2023-12-31 | 300 K |
Microbot Medical Historical Income Statement
Microbot Medical Income Statement is one of the three primary financial statements used for reporting Microbot's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Microbot Medical revenue and expense. Microbot Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Microbot Medical's Other Operating Expenses is comparatively stable compared to the past year. Total Operating Expenses is likely to gain to about 18.8 M in 2024, despite the fact that Gross Profit is likely to grow to (100.7 K). View More FundamentalsMicrobot Stock Against Markets
Picking the right benchmark for Microbot Medical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Microbot Medical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Microbot Medical is critical whether you are bullish or bearish towards Microbot Medical at a given time. Please also check how Microbot Medical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Microbot Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Microbot Medical Corporate Directors
Microbot Medical corporate directors refer to members of a Microbot Medical board of directors. The board of directors generally takes responsibility for the Microbot Medical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Microbot Medical's board members must vote for the resolution. The Microbot Medical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Prattipati Laxminarain | Independent Director | Profile | |
| Yoav Waizer | Director | Profile | |
| Yoseph Bornstein | COFounder Director | Profile | |
| Solomon Mayer | Director | Profile |
How to buy Microbot Stock?
Before investing in Microbot Medical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Microbot Medical. To buy Microbot Medical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Microbot Medical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Microbot Medical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Microbot Medical stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Microbot Medical stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Microbot Medical, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.
Already Invested in Microbot Medical?
The danger of trading Microbot Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Microbot Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Microbot Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Microbot Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Microbot Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Microbot Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Microbot Medical Stock. Highlighted below are key reports to facilitate an investment decision about Microbot Medical Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Microbot Stock analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Microbot Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Microbot Medical. If investors know Microbot will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Return On Assets (0.69) | Return On Equity (1.82) |
The market value of Microbot Medical is measured differently than its book value, which is the value of Microbot that is recorded on the company's balance sheet. Investors also form their own opinion of Microbot Medical's value that differs from its market value or its book value, called intrinsic value, which is Microbot Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Microbot Medical's market value can be influenced by many factors that don't directly affect Microbot Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Microbot Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Microbot Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Microbot Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.